11 September 2014
ASLAN featured in BioWorld
9 September 2014
ASLAN doses first patients in first clinical study
in Taiwan
27 August 2014
ASLAN chairs keynote panel at Pharma R&D Asia
in Singapore

Our Model
ASLAN inlicenses preclinical candidate drugs and takes them to proof-of-concept, leveraging high quality resources in Asia, then offers them back to the originator or other pharma companies for late phase global development.
ASLAN is currently looking to inlicense preclinical and early development compounds into our pipeline across a variety of therapeutic areas

Home | Our Model Our Team Our Board | Pipeline | Asset Partners | Latest News | Careers
    Our Advisors Our Investors         Execution Partners   Archive   Location

Copyright ©2010 ASLAN Pharmaceuticals Pte Ltd